CLINICAL_TRIALS
trial_result
· 2025-06-18
Clinical Trial Update: Low-dose Atropine for the Prevention of Myopia Progression in Danish Children [Phase 2]
Summary
A Phase 2 trial evaluating low-dose atropine to slow the progression of myopia in Danish children has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Line Kessel | Conditions: Myopia | Phase 2 | Status: COMPLETED | Results posted: 2025-06-18